Details for New Drug Application (NDA): 006459
✉ Email this page to a colleague
The generic ingredient in HETRAZAN is diethylcarbamazine citrate. There are five drug master file entries for this compound. Additional details are available on the diethylcarbamazine citrate profile page.
Summary for 006459
Tradename: | HETRAZAN |
Applicant: | Lederle |
Ingredient: | diethylcarbamazine citrate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 006459
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription